NPJ PRECIS ONCOL 润色咨询

npj Precision Oncology

出版年份：暂无数据 年文章数：271 投稿命中率： 开通期刊会员，数据随心看

出版周期：暂无数据 自引率：暂无数据 审稿周期： 开通期刊会员，数据随心看

前往期刊查询
期刊讨论 | 中国SCI论文 | 期刊主页 | 投稿经验 | 杂志官网 | 投稿链接 | 作者需知 | PMC链接 | Pubmed全文检索

期刊讨论

  1. [GetPortalCommentsPageByObjectIdResponse(id=2138790, encodeId=fd2f2138e90cb, content=有个reviewer审稿一个月了还没返回，泪奔。来点好运吧, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=46, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=06a41689219, createdName=momoxiaogu, createdTime=Wed May 24 11:52:14 CST 2023, time=2023-05-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2112943, encodeId=4341211294339, content=我, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/EQ6m8hhE9WL8e3icc1Cn1nPIyiccZvibApygJ6SSqFe2aUrB0Dy33fq4QK5n5BVq8wt5s35icw0rWa8bUycNt3wECw/132, createdBy=bf255272727, createdName=dadayi, createdTime=Fri Feb 03 23:37:28 CST 2023, time=2023-02-03, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2110423, encodeId=950a21104233e, content=求问投过的朋友，这个杂志投稿的状态都是怎样的呀, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=cb545224161, createdName=14787bdbm99(暂无昵称), createdTime=Mon Jan 16 12:27:03 CST 2023, time=2023-01-16, status=1, ipAttribution=天津), GetPortalCommentsPageByObjectIdResponse(id=1077059, encodeId=260310e705973, content=审稿速度:1.0 | 投稿命中率:5.0<br>偏重的研究方向：乳腺癌;生信<br>经验分享：官网写的初审时间是5天，我的已经13天了，还在manuscript under consideration,投的生信补实验的文章，有人有经验么？我只要能送审就很满足了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=56, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=50cd5589850, createdName=ms3000000303392842, createdTime=Sun Dec 05 12:19:44 CST 2021, time=2021-12-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1113154, encodeId=8d69111315474, content=ORCIDID是什么？怎么注册？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=41, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=bb142989248, createdName=MS68862005, createdTime=Tue Dec 28 14:52:55 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1066567, encodeId=daac106656e15, content=这个杂志似乎喜欢聚类的生信文章, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=61, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdqq.qlogo.cn/qqapp/101296147/AC155882450E4EC1FD036F717D37D497/100, createdBy=ba642497095, createdName=H·D·E, createdTime=Wed Nov 03 11:38:05 CST 2021, time=2021-11-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1013179, encodeId=cfc410131e923, content=审稿速度:2.0 | 投稿命中率:75.0<br>偏重的研究方向：乳腺癌;机器学习;免疫<br>经验分享：没什么经验, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=50cd5589850, createdName=ms3000000303392842, createdTime=Tue Aug 31 13:38:32 CST 2021, time=2021-08-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1007877, encodeId=2e72100e8773f, content=偏重的研究方向： 肿瘤 <br>经验分享：我看了一下这个期刊最近的文章，挺好的，不过审稿周期都很长，怕耽搁就没投, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=45, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a2925481605, createdName=ms9000000399989409, createdTime=Sat Aug 14 17:24:18 CST 2021, time=2021-08-14, status=1, ipAttribution=)]
    2023-05-24 momoxiaogu

    有个reviewer审稿一个月了还没返回，泪奔。来点好运吧

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=2138790, encodeId=fd2f2138e90cb, content=有个reviewer审稿一个月了还没返回，泪奔。来点好运吧, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=46, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=06a41689219, createdName=momoxiaogu, createdTime=Wed May 24 11:52:14 CST 2023, time=2023-05-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2112943, encodeId=4341211294339, content=我, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/EQ6m8hhE9WL8e3icc1Cn1nPIyiccZvibApygJ6SSqFe2aUrB0Dy33fq4QK5n5BVq8wt5s35icw0rWa8bUycNt3wECw/132, createdBy=bf255272727, createdName=dadayi, createdTime=Fri Feb 03 23:37:28 CST 2023, time=2023-02-03, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2110423, encodeId=950a21104233e, content=求问投过的朋友，这个杂志投稿的状态都是怎样的呀, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=cb545224161, createdName=14787bdbm99(暂无昵称), createdTime=Mon Jan 16 12:27:03 CST 2023, time=2023-01-16, status=1, ipAttribution=天津), GetPortalCommentsPageByObjectIdResponse(id=1077059, encodeId=260310e705973, content=审稿速度:1.0 | 投稿命中率:5.0<br>偏重的研究方向：乳腺癌;生信<br>经验分享：官网写的初审时间是5天，我的已经13天了，还在manuscript under consideration,投的生信补实验的文章，有人有经验么？我只要能送审就很满足了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=56, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=50cd5589850, createdName=ms3000000303392842, createdTime=Sun Dec 05 12:19:44 CST 2021, time=2021-12-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1113154, encodeId=8d69111315474, content=ORCIDID是什么？怎么注册？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=41, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=bb142989248, createdName=MS68862005, createdTime=Tue Dec 28 14:52:55 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1066567, encodeId=daac106656e15, content=这个杂志似乎喜欢聚类的生信文章, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=61, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdqq.qlogo.cn/qqapp/101296147/AC155882450E4EC1FD036F717D37D497/100, createdBy=ba642497095, createdName=H·D·E, createdTime=Wed Nov 03 11:38:05 CST 2021, time=2021-11-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1013179, encodeId=cfc410131e923, content=审稿速度:2.0 | 投稿命中率:75.0<br>偏重的研究方向：乳腺癌;机器学习;免疫<br>经验分享：没什么经验, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=50cd5589850, createdName=ms3000000303392842, createdTime=Tue Aug 31 13:38:32 CST 2021, time=2021-08-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1007877, encodeId=2e72100e8773f, content=偏重的研究方向： 肿瘤 <br>经验分享：我看了一下这个期刊最近的文章，挺好的，不过审稿周期都很长，怕耽搁就没投, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=45, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a2925481605, createdName=ms9000000399989409, createdTime=Sat Aug 14 17:24:18 CST 2021, time=2021-08-14, status=1, ipAttribution=)]
    2023-02-03 dadayi 来自北京

    我

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=2138790, encodeId=fd2f2138e90cb, content=有个reviewer审稿一个月了还没返回，泪奔。来点好运吧, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=46, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=06a41689219, createdName=momoxiaogu, createdTime=Wed May 24 11:52:14 CST 2023, time=2023-05-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2112943, encodeId=4341211294339, content=我, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/EQ6m8hhE9WL8e3icc1Cn1nPIyiccZvibApygJ6SSqFe2aUrB0Dy33fq4QK5n5BVq8wt5s35icw0rWa8bUycNt3wECw/132, createdBy=bf255272727, createdName=dadayi, createdTime=Fri Feb 03 23:37:28 CST 2023, time=2023-02-03, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2110423, encodeId=950a21104233e, content=求问投过的朋友，这个杂志投稿的状态都是怎样的呀, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=cb545224161, createdName=14787bdbm99(暂无昵称), createdTime=Mon Jan 16 12:27:03 CST 2023, time=2023-01-16, status=1, ipAttribution=天津), GetPortalCommentsPageByObjectIdResponse(id=1077059, encodeId=260310e705973, content=审稿速度:1.0 | 投稿命中率:5.0<br>偏重的研究方向：乳腺癌;生信<br>经验分享：官网写的初审时间是5天，我的已经13天了，还在manuscript under consideration,投的生信补实验的文章，有人有经验么？我只要能送审就很满足了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=56, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=50cd5589850, createdName=ms3000000303392842, createdTime=Sun Dec 05 12:19:44 CST 2021, time=2021-12-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1113154, encodeId=8d69111315474, content=ORCIDID是什么？怎么注册？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=41, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=bb142989248, createdName=MS68862005, createdTime=Tue Dec 28 14:52:55 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1066567, encodeId=daac106656e15, content=这个杂志似乎喜欢聚类的生信文章, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=61, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdqq.qlogo.cn/qqapp/101296147/AC155882450E4EC1FD036F717D37D497/100, createdBy=ba642497095, createdName=H·D·E, createdTime=Wed Nov 03 11:38:05 CST 2021, time=2021-11-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1013179, encodeId=cfc410131e923, content=审稿速度:2.0 | 投稿命中率:75.0<br>偏重的研究方向：乳腺癌;机器学习;免疫<br>经验分享：没什么经验, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=50cd5589850, createdName=ms3000000303392842, createdTime=Tue Aug 31 13:38:32 CST 2021, time=2021-08-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1007877, encodeId=2e72100e8773f, content=偏重的研究方向： 肿瘤 <br>经验分享：我看了一下这个期刊最近的文章，挺好的，不过审稿周期都很长，怕耽搁就没投, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=45, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a2925481605, createdName=ms9000000399989409, createdTime=Sat Aug 14 17:24:18 CST 2021, time=2021-08-14, status=1, ipAttribution=)]
    2023-01-16 14787bdbm99(暂无昵称) 来自天津

    求问投过的朋友，这个杂志投稿的状态都是怎样的呀

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=2138790, encodeId=fd2f2138e90cb, content=有个reviewer审稿一个月了还没返回，泪奔。来点好运吧, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=46, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=06a41689219, createdName=momoxiaogu, createdTime=Wed May 24 11:52:14 CST 2023, time=2023-05-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2112943, encodeId=4341211294339, content=我, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/EQ6m8hhE9WL8e3icc1Cn1nPIyiccZvibApygJ6SSqFe2aUrB0Dy33fq4QK5n5BVq8wt5s35icw0rWa8bUycNt3wECw/132, createdBy=bf255272727, createdName=dadayi, createdTime=Fri Feb 03 23:37:28 CST 2023, time=2023-02-03, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2110423, encodeId=950a21104233e, content=求问投过的朋友，这个杂志投稿的状态都是怎样的呀, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=cb545224161, createdName=14787bdbm99(暂无昵称), createdTime=Mon Jan 16 12:27:03 CST 2023, time=2023-01-16, status=1, ipAttribution=天津), GetPortalCommentsPageByObjectIdResponse(id=1077059, encodeId=260310e705973, content=审稿速度:1.0 | 投稿命中率:5.0<br>偏重的研究方向：乳腺癌;生信<br>经验分享：官网写的初审时间是5天，我的已经13天了，还在manuscript under consideration,投的生信补实验的文章，有人有经验么？我只要能送审就很满足了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=56, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=50cd5589850, createdName=ms3000000303392842, createdTime=Sun Dec 05 12:19:44 CST 2021, time=2021-12-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1113154, encodeId=8d69111315474, content=ORCIDID是什么？怎么注册？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=41, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=bb142989248, createdName=MS68862005, createdTime=Tue Dec 28 14:52:55 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1066567, encodeId=daac106656e15, content=这个杂志似乎喜欢聚类的生信文章, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=61, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdqq.qlogo.cn/qqapp/101296147/AC155882450E4EC1FD036F717D37D497/100, createdBy=ba642497095, createdName=H·D·E, createdTime=Wed Nov 03 11:38:05 CST 2021, time=2021-11-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1013179, encodeId=cfc410131e923, content=审稿速度:2.0 | 投稿命中率:75.0<br>偏重的研究方向：乳腺癌;机器学习;免疫<br>经验分享：没什么经验, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=50cd5589850, createdName=ms3000000303392842, createdTime=Tue Aug 31 13:38:32 CST 2021, time=2021-08-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1007877, encodeId=2e72100e8773f, content=偏重的研究方向： 肿瘤 <br>经验分享：我看了一下这个期刊最近的文章，挺好的，不过审稿周期都很长，怕耽搁就没投, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=45, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a2925481605, createdName=ms9000000399989409, createdTime=Sat Aug 14 17:24:18 CST 2021, time=2021-08-14, status=1, ipAttribution=)]
    2021-12-05 ms3000000303392842

    审稿速度:1.0 | 投稿命中率:5.0
    偏重的研究方向：乳腺癌;生信
    经验分享：官网写的初审时间是5天，我的已经13天了，还在manuscript under consideration,投的生信补实验的文章，有人有经验么？我只要能送审就很满足了。

    3

    展开3条回复
  5. [GetPortalCommentsPageByObjectIdResponse(id=2138790, encodeId=fd2f2138e90cb, content=有个reviewer审稿一个月了还没返回，泪奔。来点好运吧, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=46, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=06a41689219, createdName=momoxiaogu, createdTime=Wed May 24 11:52:14 CST 2023, time=2023-05-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2112943, encodeId=4341211294339, content=我, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/EQ6m8hhE9WL8e3icc1Cn1nPIyiccZvibApygJ6SSqFe2aUrB0Dy33fq4QK5n5BVq8wt5s35icw0rWa8bUycNt3wECw/132, createdBy=bf255272727, createdName=dadayi, createdTime=Fri Feb 03 23:37:28 CST 2023, time=2023-02-03, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2110423, encodeId=950a21104233e, content=求问投过的朋友，这个杂志投稿的状态都是怎样的呀, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=cb545224161, createdName=14787bdbm99(暂无昵称), createdTime=Mon Jan 16 12:27:03 CST 2023, time=2023-01-16, status=1, ipAttribution=天津), GetPortalCommentsPageByObjectIdResponse(id=1077059, encodeId=260310e705973, content=审稿速度:1.0 | 投稿命中率:5.0<br>偏重的研究方向：乳腺癌;生信<br>经验分享：官网写的初审时间是5天，我的已经13天了，还在manuscript under consideration,投的生信补实验的文章，有人有经验么？我只要能送审就很满足了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=56, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=50cd5589850, createdName=ms3000000303392842, createdTime=Sun Dec 05 12:19:44 CST 2021, time=2021-12-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1113154, encodeId=8d69111315474, content=ORCIDID是什么？怎么注册？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=41, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=bb142989248, createdName=MS68862005, createdTime=Tue Dec 28 14:52:55 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1066567, encodeId=daac106656e15, content=这个杂志似乎喜欢聚类的生信文章, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=61, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdqq.qlogo.cn/qqapp/101296147/AC155882450E4EC1FD036F717D37D497/100, createdBy=ba642497095, createdName=H·D·E, createdTime=Wed Nov 03 11:38:05 CST 2021, time=2021-11-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1013179, encodeId=cfc410131e923, content=审稿速度:2.0 | 投稿命中率:75.0<br>偏重的研究方向：乳腺癌;机器学习;免疫<br>经验分享：没什么经验, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=50cd5589850, createdName=ms3000000303392842, createdTime=Tue Aug 31 13:38:32 CST 2021, time=2021-08-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1007877, encodeId=2e72100e8773f, content=偏重的研究方向： 肿瘤 <br>经验分享：我看了一下这个期刊最近的文章，挺好的，不过审稿周期都很长，怕耽搁就没投, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=45, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a2925481605, createdName=ms9000000399989409, createdTime=Sat Aug 14 17:24:18 CST 2021, time=2021-08-14, status=1, ipAttribution=)]
    2021-12-28 MS68862005

    ORCIDID是什么？怎么注册？

    1

    展开1条回复
  6. [GetPortalCommentsPageByObjectIdResponse(id=2138790, encodeId=fd2f2138e90cb, content=有个reviewer审稿一个月了还没返回，泪奔。来点好运吧, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=46, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=06a41689219, createdName=momoxiaogu, createdTime=Wed May 24 11:52:14 CST 2023, time=2023-05-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2112943, encodeId=4341211294339, content=我, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/EQ6m8hhE9WL8e3icc1Cn1nPIyiccZvibApygJ6SSqFe2aUrB0Dy33fq4QK5n5BVq8wt5s35icw0rWa8bUycNt3wECw/132, createdBy=bf255272727, createdName=dadayi, createdTime=Fri Feb 03 23:37:28 CST 2023, time=2023-02-03, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2110423, encodeId=950a21104233e, content=求问投过的朋友，这个杂志投稿的状态都是怎样的呀, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=cb545224161, createdName=14787bdbm99(暂无昵称), createdTime=Mon Jan 16 12:27:03 CST 2023, time=2023-01-16, status=1, ipAttribution=天津), GetPortalCommentsPageByObjectIdResponse(id=1077059, encodeId=260310e705973, content=审稿速度:1.0 | 投稿命中率:5.0<br>偏重的研究方向：乳腺癌;生信<br>经验分享：官网写的初审时间是5天，我的已经13天了，还在manuscript under consideration,投的生信补实验的文章，有人有经验么？我只要能送审就很满足了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=56, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=50cd5589850, createdName=ms3000000303392842, createdTime=Sun Dec 05 12:19:44 CST 2021, time=2021-12-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1113154, encodeId=8d69111315474, content=ORCIDID是什么？怎么注册？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=41, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=bb142989248, createdName=MS68862005, createdTime=Tue Dec 28 14:52:55 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1066567, encodeId=daac106656e15, content=这个杂志似乎喜欢聚类的生信文章, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=61, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdqq.qlogo.cn/qqapp/101296147/AC155882450E4EC1FD036F717D37D497/100, createdBy=ba642497095, createdName=H·D·E, createdTime=Wed Nov 03 11:38:05 CST 2021, time=2021-11-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1013179, encodeId=cfc410131e923, content=审稿速度:2.0 | 投稿命中率:75.0<br>偏重的研究方向：乳腺癌;机器学习;免疫<br>经验分享：没什么经验, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=50cd5589850, createdName=ms3000000303392842, createdTime=Tue Aug 31 13:38:32 CST 2021, time=2021-08-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1007877, encodeId=2e72100e8773f, content=偏重的研究方向： 肿瘤 <br>经验分享：我看了一下这个期刊最近的文章，挺好的，不过审稿周期都很长，怕耽搁就没投, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=45, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a2925481605, createdName=ms9000000399989409, createdTime=Sat Aug 14 17:24:18 CST 2021, time=2021-08-14, status=1, ipAttribution=)]
    2021-11-03 H·D·E

    这个杂志似乎喜欢聚类的生信文章

    0

  7. [GetPortalCommentsPageByObjectIdResponse(id=2138790, encodeId=fd2f2138e90cb, content=有个reviewer审稿一个月了还没返回，泪奔。来点好运吧, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=46, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=06a41689219, createdName=momoxiaogu, createdTime=Wed May 24 11:52:14 CST 2023, time=2023-05-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2112943, encodeId=4341211294339, content=我, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/EQ6m8hhE9WL8e3icc1Cn1nPIyiccZvibApygJ6SSqFe2aUrB0Dy33fq4QK5n5BVq8wt5s35icw0rWa8bUycNt3wECw/132, createdBy=bf255272727, createdName=dadayi, createdTime=Fri Feb 03 23:37:28 CST 2023, time=2023-02-03, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2110423, encodeId=950a21104233e, content=求问投过的朋友，这个杂志投稿的状态都是怎样的呀, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=cb545224161, createdName=14787bdbm99(暂无昵称), createdTime=Mon Jan 16 12:27:03 CST 2023, time=2023-01-16, status=1, ipAttribution=天津), GetPortalCommentsPageByObjectIdResponse(id=1077059, encodeId=260310e705973, content=审稿速度:1.0 | 投稿命中率:5.0<br>偏重的研究方向：乳腺癌;生信<br>经验分享：官网写的初审时间是5天，我的已经13天了，还在manuscript under consideration,投的生信补实验的文章，有人有经验么？我只要能送审就很满足了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=56, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=50cd5589850, createdName=ms3000000303392842, createdTime=Sun Dec 05 12:19:44 CST 2021, time=2021-12-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1113154, encodeId=8d69111315474, content=ORCIDID是什么？怎么注册？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=41, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=bb142989248, createdName=MS68862005, createdTime=Tue Dec 28 14:52:55 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1066567, encodeId=daac106656e15, content=这个杂志似乎喜欢聚类的生信文章, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=61, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdqq.qlogo.cn/qqapp/101296147/AC155882450E4EC1FD036F717D37D497/100, createdBy=ba642497095, createdName=H·D·E, createdTime=Wed Nov 03 11:38:05 CST 2021, time=2021-11-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1013179, encodeId=cfc410131e923, content=审稿速度:2.0 | 投稿命中率:75.0<br>偏重的研究方向：乳腺癌;机器学习;免疫<br>经验分享：没什么经验, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=50cd5589850, createdName=ms3000000303392842, createdTime=Tue Aug 31 13:38:32 CST 2021, time=2021-08-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1007877, encodeId=2e72100e8773f, content=偏重的研究方向： 肿瘤 <br>经验分享：我看了一下这个期刊最近的文章，挺好的，不过审稿周期都很长，怕耽搁就没投, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=45, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a2925481605, createdName=ms9000000399989409, createdTime=Sat Aug 14 17:24:18 CST 2021, time=2021-08-14, status=1, ipAttribution=)]
    2021-08-31 ms3000000303392842

    审稿速度:2.0 | 投稿命中率:75.0
    偏重的研究方向：乳腺癌;机器学习;免疫
    经验分享：没什么经验

    0

  8. [GetPortalCommentsPageByObjectIdResponse(id=2138790, encodeId=fd2f2138e90cb, content=有个reviewer审稿一个月了还没返回，泪奔。来点好运吧, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=46, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=06a41689219, createdName=momoxiaogu, createdTime=Wed May 24 11:52:14 CST 2023, time=2023-05-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2112943, encodeId=4341211294339, content=我, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/EQ6m8hhE9WL8e3icc1Cn1nPIyiccZvibApygJ6SSqFe2aUrB0Dy33fq4QK5n5BVq8wt5s35icw0rWa8bUycNt3wECw/132, createdBy=bf255272727, createdName=dadayi, createdTime=Fri Feb 03 23:37:28 CST 2023, time=2023-02-03, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2110423, encodeId=950a21104233e, content=求问投过的朋友，这个杂志投稿的状态都是怎样的呀, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=cb545224161, createdName=14787bdbm99(暂无昵称), createdTime=Mon Jan 16 12:27:03 CST 2023, time=2023-01-16, status=1, ipAttribution=天津), GetPortalCommentsPageByObjectIdResponse(id=1077059, encodeId=260310e705973, content=审稿速度:1.0 | 投稿命中率:5.0<br>偏重的研究方向：乳腺癌;生信<br>经验分享：官网写的初审时间是5天，我的已经13天了，还在manuscript under consideration,投的生信补实验的文章，有人有经验么？我只要能送审就很满足了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=56, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=50cd5589850, createdName=ms3000000303392842, createdTime=Sun Dec 05 12:19:44 CST 2021, time=2021-12-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1113154, encodeId=8d69111315474, content=ORCIDID是什么？怎么注册？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=41, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=bb142989248, createdName=MS68862005, createdTime=Tue Dec 28 14:52:55 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1066567, encodeId=daac106656e15, content=这个杂志似乎喜欢聚类的生信文章, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=61, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdqq.qlogo.cn/qqapp/101296147/AC155882450E4EC1FD036F717D37D497/100, createdBy=ba642497095, createdName=H·D·E, createdTime=Wed Nov 03 11:38:05 CST 2021, time=2021-11-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1013179, encodeId=cfc410131e923, content=审稿速度:2.0 | 投稿命中率:75.0<br>偏重的研究方向：乳腺癌;机器学习;免疫<br>经验分享：没什么经验, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=50cd5589850, createdName=ms3000000303392842, createdTime=Tue Aug 31 13:38:32 CST 2021, time=2021-08-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1007877, encodeId=2e72100e8773f, content=偏重的研究方向： 肿瘤 <br>经验分享：我看了一下这个期刊最近的文章，挺好的，不过审稿周期都很长，怕耽搁就没投, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=45, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a2925481605, createdName=ms9000000399989409, createdTime=Sat Aug 14 17:24:18 CST 2021, time=2021-08-14, status=1, ipAttribution=)]
    2021-08-14 ms9000000399989409

    偏重的研究方向： 肿瘤
    经验分享：我看了一下这个期刊最近的文章，挺好的，不过审稿周期都很长，怕耽搁就没投

    1

    展开1条回复
共48条页码: 2/5页10条/页
分享您的投稿经验，提升MI经验值，获取更多积分